This site is part of the Informa Connect Division of Informa PLC

该网站由Informa Plc拥有的业务或企业运营，所有版权所有于它们。Informa Plc的注册办事处是伦敦SW1P 1WG伦敦豪克斯的录入办公室。在英格兰和威尔士注册。数字3099067。

Browse our events, training, articles and people by topicclose

普遍的部门

A - Z

Browse Topics apps close
search

Cell & Gene Therapy

Fast track cell, gene & car-t commercialization from concept to robust patient-centric delivery.

Articles & Video

Showing 22 of 100 articles & video
特色
Cell and Gene Therapies

电子书：细胞和基因治疗行业的未来

从细胞和基因治疗部门接下来，我们可以预期什么？该电子书从优化的Car-T探讨了前方的潜在路径，以自动化生物处理。
特色
分析方法

细胞和基因疗法的新型分析策略和工具 - 白皮书

What analytical techniques can be applied to production of cell therapies, gene therapies and gene-edited cell-therapies? This whitepaper looks at the latest examples.
Digital Week

BioProcess International Fall Digital Week 2020

We explore the agenda for the upcoming BioProcess International Fall Digital Week 2020.
BioProcess International

BioProcess International 2020 Post-Event Report

Explore the highlights of the BioProcess International 2020 virtual conference in the post-event round-up.
COVID-19

报告：通过大流行金博宝188备用地址的制药合作和交易

This Informa report explores how partnering and deal-making in the pharma industry has been impacted by COVID-19.
Drug Manufacturing

When to outsource manufacturing? Advice for cell and gene therapy developers

What scenarios could determine when is best to outsource manufacturing of cell and gene therapies to a CDMO?
Healthcare

REPORT: The Future of Healthcare Post COVID-19

In our latest report learn how healthcare organizations are adapting to succeed post COVID-19, from innovation to product development.
Vector manufacturing

Viral vectors have biggest limitations in vector manufacturing, according to industry survey

Exploring results of our industry survey, we identify the biggest pain points in vector manufacturing experienced by cell and gene therapy professionals.
Vectors

Vector manufacturing for cell and gene therapies: how should current platforms be changed?

What do we need from vector manufacturing platforms to deliver commercial scale therapies? We look at responses from industry insiders.
多元化和包容性

Pharma的妇女：44％的制药专业人士认为，妇女在其组织中代表

44% of pharma professionals think that women are under represented in their organization according to new data from an Informa Connect Life Sciences study. Here we deep dive into the data.
Diversity

生物技术的多样性和包容

The life science industry has a challenge to become more equal, diverse and inclusive. Join us at Diversity and Inclusion in Biotech, September 22nd and find out how TOGETHER we can make a difference.
ChinaBio Partnering Forum 2020

采访 - j＆j对生命科学创新，伙伴关系和先进技术的多管途径方法

Dr. Dan Wang, Head, Johnson & Johnson Innovation, Asia Pacific, and Dr. Sharon Chan, Head of JLABS @ Shanghai discuss its support of startups, interests in diverse disease areas, the importance of collaborations and much more in this exclusive interview with EBD Group.
Biopharma.

调查：通过大流行金博宝188备用地址合作和交易生物牧师

在Covid-19期间，我们正在进行一个巨大的研究，以便在Covid-19和大流行的商业后果中进行生物食花牧场交易的观点。参加这里。
Automation

Automating cell and gene therapy manufacturing: challenges and approaches

With the pressure on to scale up manufacturing of cell and gene therapies, what steps should organizations take to optimize their processes with automation? We asked three industry experts for their advice.
Cell therapies

42% of pharma industry believe cell and gene therapies to be most promising therapeutics

According to a recent study, 42% of pharma industry professionals predict cell and gene therapies are the therapeutic area that will see the fastest growth in the next 10 years.
Vectors

Cell and Gene Therapy Report 2020: Viral and Non-viral Vectors

我们最近的全球行业调查的报告揭示了病毒和非病毒载体制造中的最大挑战，用于细胞和基因疗法。
ChinaBio Partnering Forum 2020

Top Biotech Deals in China

Discover the deals transforming China biotech! More than $12 billion in biopharma financing, alliances, IPOs, and new funds have been generated so far this year in China. Learn the details of these deals when you read this new free infographic.
COVID-19

80% of life sciences professionals predict a COVID-19 vaccine will be approved within 18 months

How quickly to life sciences professionals predict a COVID-19 vaccine will be approved and what are the main obstacles? We explore.
Life Sciences

The biggest breakthroughs in life sciences the last 10 years

CRISPR，CAR-T，免疫疗法，基因组测序，AI - 过去10年的生命科学最大的突破是什么？
Premiumget_app
大车

Gene-Edited Cell Therapies: CMC Challenges and Considerations - WHITEPAPER

This whitepaper reviews the current challenges in manufacturing gene-edited cell therapies and ways to approach them, presenting key case studies.
Non-viral vectors

Technologies and Novel Platforms for Optimizing Cell and Gene Therapies

该交互式电子书探讨了通过新兴技术和平台解决的细胞和基因治疗行业中的独特挑战。
Premiumget_app
多元化和包容性

Diversity in the life sciences workplace: Implementing a leading corporate culture for innovation - WHITEPAPER

本文着眼于如何富士达er racial, gender, geographical, neuro and cognitive diversity in the life sciences to achieve an inclusive culture built for innovation.

版权所有©2020.金宝搏App下载